Status not kept up to date

Safety Evaluation of the ReWalk ReStore Device in Subjects With Mobility Impairments Due to Stroke

NCT03499210 · ReWalk Robotics, Inc. · Updated 7 Nov 2018

What is being tested: ReWalk ReStore device
For: Stroke; Stroke, Acute; Stroke Hemorrhagic; Hemiparesis; Hemiplegia; Cerebrovascular Accident
Kind of study: Tests a treatment or device on volunteers. No drug phase (a device or procedure study).
Who can join: Ages 18 years and older. About 40 people. The full rules are on the registry page.
Where: United States (5 sites)
When: Starts or started 29 March 2018, ends 30 Nov 2018. Registered 17 April 2018.
Results: None posted yet.

In the researchers' words

A multi-site, interventional, non-comparative, single-arm trial to evaluate the safety of the ReWalk ReStore device in subjects with hemiplegia/hemiparesis due to ischemic or hemorrhagic stroke.

ClinicalTrials.gov, NCT03499210

Sites

Shirley Ryan AbilityLabChicago, Illinois, United States
Spaulding Rehabilitation InstituteBoston, Massachusetts, United States
Kessler FoundationWest Orange, New Jersey, United States
Moss RehabElkins Park, Pennsylvania, United States
TIRR Memorial HermannHouston, Texas, United States